Formalising the induction of patient and public involvement contributors on trial oversight committees

por Pickering, Emily C., Hanley, Bec, Bell, Philip, Gath, Jacqui, Hanlon, Patrick, Oldroyd, Robert, Stephens, Richard, Tweed, Conor D.
Publicado 2021

Models and impact of patient and public involvement in studies carried out by the Medical Research Council Clinical Trials Unit at University College London: findings from ten case...

por South, Annabelle, Hanley, Bec, Gafos, Mitzy, Cromarty, Ben, Stephens, Richard, Sturgeon, Kate, Scott, Karen, Cragg, William J., Tweed, Conor D., Teera, Jacqueline, Vale, Claire L.
Publicado 2016

Erratum to: ‘Models and impact of patient and public involvement in studies carried out by the Medical Research Council Clinical Trials Unit at University College London: findings...

por South, Annabelle, Hanley, Bec, Gafos, Mitzy, Cromarty, Ben, Stephens, Richard, Sturgeon, Kate, Scott, Karen, Cragg, William J., Tweed, Conor D., Teera, Jacqueline, Vale, Claire L.
Publicado 2016

Treatment estimands in clinical trials of patients hospitalised for COVID-19: ensuring trials ask the right questions

por Kahan, Brennan C., Morris, Tim P., White, Ian R., Tweed, Conor D., Cro, Suzie, Dahly, Darren, Pham, Tra My, Esmail, Hanif, Babiker, Abdel, Carpenter, James R.
Publicado 2020

Rethinking intercurrent events in defining estimands for tuberculosis trials

por Pham, Tra My, Tweed, Conor D, Carpenter, James R, Kahan, Brennan C, Nunn, Andrew J, Crook, Angela M, Esmail, Hanif, Goodall, Ruth, Phillips, Patrick PJ, White, Ian R
Publicado 2022

Toxicity related to standard TB therapy for pulmonary tuberculosis and treatment outcomes in the REMoxTB study according to HIV status

por Tweed, Conor D., Crook, Angela M., Dawson, Rodney, Diacon, Andreas H., McHugh, Timothy D., Mendel, Carl M., Meredith, Sarah K., Mohapi, Lerato, Murphy, Michael E., Nunn, Andrew J., Phillips, Patrick P. J., Singh, Kasha P., Spigelman, Melvin, Gillespie, Stephen H.
Publicado 2019

Toxicity associated with tuberculosis chemotherapy in the REMoxTB study

por Tweed, Conor D., Crook, Angela M., Amukoye, Evans I., Dawson, Rodney, Diacon, Andreas H., Hanekom, Madeline, McHugh, Timothy D., Mendel, Carl M., Meredith, Sarah K., Murphy, Michael E., Murthy, Saraswathi E., Nunn, Andrew J., Phillips, Patrick P. J., Singh, Kasha P., Spigelman, Melvin, Wills, Genevieve H., Gillespie, Stephen H.
Publicado 2018

Bedaquiline, moxifloxacin, pretomanid, and pyrazinamide during the first 8 weeks of treatment of patients with drug-susceptible or drug-resistant pulmonary tuberculosis: a multicen...

por Tweed, Conor D, Dawson, Rodney, Burger, Divan A, Conradie, Almari, Crook, Angela M, Mendel, Carl M, Conradie, Francesca, Diacon, Andreas H, Ntinginya, Nyanda E, Everitt, Daniel E, Haraka, Frederick, Li, Mengchun, van Niekerk, Christo H, Okwera, Alphonse, Rassool, Mohammed S, Reither, Klaus, Sebe, Modulakgotla A, Staples, Suzanne, Variava, Ebrahim, Spigelman, Melvin
Publicado 2019